A. E. Eskazan Et Al. , "The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia," LEUKEMIA & LYMPHOMA , vol.55, no.12, pp.2935-2937, 2014
Eskazan, A. E. Et Al. 2014. The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia. LEUKEMIA & LYMPHOMA , vol.55, no.12 , 2935-2937.
Eskazan, A. E., ELVERDİ, T., Yalniz, F. F., Salihoglu, A., AR, M. C., Aydin, S. O., ... Baslar, Z.(2014). The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia. LEUKEMIA & LYMPHOMA , vol.55, no.12, 2935-2937.
Eskazan, Ahmet Et Al. "The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia," LEUKEMIA & LYMPHOMA , vol.55, no.12, 2935-2937, 2014
Eskazan, Ahmet E. Et Al. "The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia." LEUKEMIA & LYMPHOMA , vol.55, no.12, pp.2935-2937, 2014
Eskazan, A. E. Et Al. (2014) . "The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia." LEUKEMIA & LYMPHOMA , vol.55, no.12, pp.2935-2937.
@article{article, author={Ahmet Emre Eskazan Et Al. }, title={The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia}, journal={LEUKEMIA & LYMPHOMA}, year=2014, pages={2935-2937} }